From: Prevalence and predictors of outcomes among ESRD patients with COVID-19
Adjusted OR | 95% Wald Confidence Limits | P -Value | ||
---|---|---|---|---|
Age | 1.064 | 1.051 | 1.077 | < 0.001 |
Race | ||||
Asian vs Blacks | 0.645 | 0.123 | 3.396 | 0.61 |
Multiracial vs Blacks | 1.522 | 0.393 | 5.892 | 0.54 |
Unknown vs Blacks | 0.771 | 0.490 | 1.213 | 0.26 |
Whites vs Blacks | 0.367 | 0.174 | 0.776 | 0.009 |
Sex (Female vs Male) | 0.452 | 0.316 | 0.648 | < 0.001 |
Insurance (None vs Private) | 3.124 | 1.695 | 5.759 | < 0.001 |
Insurance (Public vs Private) | 1.698 | 1.046 | 2.755 | 0.03 |
Heart Failure | 1.413 | 0.790 | 2.527 | 0.24 |
CAD | 1.457 | 0.943 | 2.251 | 0.09 |
Obesity | 1.722 | 0.905 | 3.277 | 0.10 |
Diabetes | 1.617 | 1.115 | 2.346 | 0.01 |
Hypertension | 0.895 | 0.610 | 1.313 | 0.57 |
ESRD status | 1.215 | 0.623 | 2.370 | 0.57 |